Intravenous Iron Treatment for Iron Deficiency in Heart Failure Patients: Assessing Clinical Outcome Improvement,
Role: Investigator,
LLU Dept. of Pharmacy Practice,
(06/2024)
Status: Approved
Evaluation of Sodium-glucose Cotransporter-2 inhibitors on Euglycemic Diabetic Ketoacidosis in Patients Admitted to an Academic Medical Center,
Role: PI,
LLU Dept. of Pharmacy Practice,
(08/2023)
Status: Approved
Comparing the efficacy and safety of IV acetazolamide and IV loop diuretics versus thiazides and IV loop diuretics in the management of Acute Decompensated Heart Failure (ADHF),
Role: PI,
LLU Dept. of Pharmacy Practice,
(08/2023)
Status: Approved
Appropriateness of antithrombotic agents in patients seen in an electrophysiology clinic setting,
Role: PI,
LLU Dept. of Pharmacy Practice,
(07/2022)
Status: Approved
Pharmacist-led Medication Reconciliation and Medication Review as an Interprofessional Collaborative Approach to Patient Care at an Arrhythmia Clinic,
Role: PI,
LLU Dept. of Pharmacy Practice,
(09/2021)
Status: Approved
Appropriateness of aspirin in addition to anticoagulation in patients seen in an electrophysiology clinic setting,
Role: PI,
LLU Dept. of Pharmacy Practice,
(09/2021)
Status: Approved
Epstein-Barr viremia treatment with oral valganciclovir and intravenous immune globulin in pediatric cardiac transplant patients,
Role: Investigator,
LLU Dept. of Pediatrics,
(08/2021)
Status: Approved
Ivabradine Therapy Appropriateness and Its Implications for Heart Failure Patients,
Role: Investigator,
LLU Dept. of Pharmacy Practice,
(03/2021)
Status: Approved
Risk of Diabetic Ketoacidosis with Sodium-glucose Cotransporter-2 Inhibitor Use,
Role: PI,
LLU Dept. of Pharmacy Practice,
(03/2021)
Status: Approved
Evaluation of the impact of holidays on INR in patients anticoagulated on warfarin at a multidisciplinary, outpatient clinic,
Role: PI,
LLU Dept. of Pharmacy Practice,
(09/2020 - 09/2024)
Status: Completed
Evaluation of the impact of holidays on INR in patients taking warfarin at a multidisciplinary clinic,
Role: PI,
LLU Dept. of Pharmacy Practice,
(10/2019 - 06/2020)
Status: Completed
Evaluation of thromboembolic and bleeding outcomes in patients with severe renal impairment with atrial fibrillation treated with direct oral anticoagulants (DOACs) from a multi-disciplinary clinic,
Role: PI,
LLU Dept. of Pharmacy Practice,
(09/2017 - 09/2018)
Status: Completed
Retrospective evaluation of immunosuppression therapy of heart transplantation patients who received HeartMate II assist device,
Role: PI,
LLU Dept. of Pharmacy Practice,
(08/2017 - 08/2018)
Status: Completed
Transition of care pharmacist interventions of heart failure patients,
Role: PI,
LLU School of Pharmacy,
(07/2017 - 07/2018)
Status: Completed
Evaluation of thromboembolic and bleeding outcomes of obese patients with atrial fibrillation treated with direct oral anticoagulant (DOACS) from a multi-disciplinary clinic,
Role: PI,
LLU Dept. of Pharmacy Practice,
(10/2016 - 10/2017)
Status: Completed
Evaluation of treating elevated pulmonary arterial pressures with phosphodiesterase-5 inhibitors in patients with left ventricular assist device,
Role: PI,
LLU Dept. of Pharmacy Practice,
(11/2015 - 11/2016)
Status: Completed
Evaluation of the use of target-specific oral anticoagulants in real-world in patients with atrial fibrillation,
Role: PI,
LLU Dept. of Pharmacy Practice,
(09/2014 - 09/2015)
Status: Completed
Outcome assessment of patients with atrial fibrillation in International Heart Institute,
Role: Investigator,
LLU Dept. of Pharmacotherapy and Outcomes Sciences,
(03/2012 - 03/2013)
Status: Completed
Herbal use among a southern California Vietnamese population,
Role: Investigator,
LLU School of Pharmacy,
(08/2008)
Status: Completed
Outpatient Intravenous Furosemide for Patients with Heart Failure,
Role: PI,
LLU Dept. of Pharmacy Practice,
(10/2024)
Status: Approved